Award

Delivery Order #SPE2DR26FAVPP

AmerisourceBergen Drug Corp Awarded Delivery Order for Vyvanse Medication

Buyer

Defense Logistics Agency

Award Amount

$2,590.14

Ceiling

$2,590.14

Awarded

February 20, 2026

Period of Performance

Feb 20, 2026 – Feb 23, 2026

Identifier

SPE2DR26FAVPP

NAICS

325411

This contract is a delivery order awarded to AmerisourceBergen Drug Corp, a prominent pharmaceutical services company, for the procurement of Vyvanse 50mg medication. The delivery order is a task under the broader indefinite delivery vehicle (IDV) held by AmerisourceBergen, which supports pharmaceutical supply chain operations primarily in European regions. The awarded order involves the supply of a specific dosage and quantity of Vyvanse, a medication commonly used for attention deficit hyperactivity disorder (ADHD), highlighting its importance in healthcare provisioning. The contract underpins critical pharmaceutical distribution efforts, ensuring timely and reliable medication availability for government or institutional needs. This particular delivery order was competitively awarded as an extension of the existing IDV, supporting an ongoing long-term procurement strategy. The timeline for this delivery order is short-term, spanning a few days, reflecting a focused and immediate fulfillment requirement. The contract contributes to the wider goal of sustaining essential medication supply chains and enhancing healthcare service outcomes.

Description

4570896186!VYVANSE 50MG 100S

View original record